Ipamorelin/CJC-1295 (w/o DAC)

Ipamorelin / CJC-1295 (Without DAC) Research Peptide Blend

Ipamorelin / CJC-1295 (without DAC) is a research peptide blend supplied for controlled laboratory investigation. Researchers study this combination in structured research focused on peptide signaling, receptor interaction models, and sequence specific behavior within experimental systems. The absence of a Drug Affinity Complex allows laboratories to examine peptide activity without extended binding modifications.

Because this blend combines two distinct peptides, researchers use it to explore how paired peptide signaling behaves under controlled research conditions. The non-DAC form of CJC-1295 allows scientists to study shorter acting peptide dynamics and interaction patterns within experimental models. As a result, laboratories can generate clear and repeatable data while maintaining precise control over experimental variables.

In laboratory settings, scientists handle Ipamorelin / CJC-1295 (without DAC) using standard peptide preparation and safety procedures. The peptide format supports accurate measurement and controlled application during experiments. Therefore, research teams can maintain stable testing conditions and focus on observation, documentation, and data analysis.

Researchers value this peptide blend for its defined structure and compatibility with structured research workflows. Its consistent composition helps reduce variation during experimentation and supports comparison across studies involving single and combined peptide sequences. In addition, the non-DAC formulation makes it suitable for research projects that focus on peptide behavior without extended binding effects.

Ongoing scientific research continues to include Ipamorelin / CJC-1295 (without DAC) in peptide focused laboratory studies. Its defined composition, predictable handling characteristics, and suitability for controlled research models make it a useful tool for advanced experimental work.

Important Notice

Ipamorelin / CJC-1295 (without DAC) is provided strictly for research use only. This product is not intended for human or animal use, clinical applications, diagnostic procedures, or consumption of any kind. All research must be conducted by qualified professionals in appropriate laboratory environments and in compliance with applicable regulations and guidelines.

No research information available for this product.

Lot Number: IPCJD127202G-J Purity: 99.8% Date: February 6, 2026 View COA Archive

Peptide Research Overview

Peptides are short chains of amino acids studied for their role in cellular signaling and molecular interactions. In research settings, they are commonly used to explore biological pathways and structure–function relationships.

Across scientific disciplines, peptide research supports advances in biochemistry and molecular biology. Their precision and adaptability make peptides essential tools in modern laboratory research.

Key Benefits of Peptides in Research

• Support precise investigation of cellular signaling pathways

• Enable targeted structure–function research at the molecular level

• Offer high specificity for controlled experimental design

• Adapt easily across a wide range of research applications

• Aid in studying protein interactions and biological responses

• Allow consistent and repeatable laboratory testing

• Integrate well with modern analytical and research methods

• Serve as foundational tools in biochemical and molecular research

Advancing Scientific Research with Peptides

Peptides continue to serve as essential components in modern research due to their flexibility, precision, and well-defined structures. In laboratory settings, researchers rely on peptides to examine biological mechanisms, evaluate molecular interactions, and refine experimental models with a high level of control. Their scalable nature and compatibility with advanced analytical techniques make peptides valuable across both foundational studies and ongoing research development, supporting consistent, reproducible outcomes in controlled scientific environments.

Ipamorelin is a synthetic peptide that acts on the ghrelin receptor (growth hormone secretagogue receptor) to promote growth hormone secretagogue signaling, while CJC-1295 (without DAC), also known as Modified GRF (1-29), is a growth hormone-releasing hormone analogue that targets the GHRH receptor. Combined, they engage distinct pathways to investigate coordinated activation of growth hormone axis signaling.

Ipamorelin activates the ghrelin receptor (GHS-R1a), triggering intracellular signaling cascades, including calcium mobilization, that are associated with the stimulation of growth hormone release from pituitary cells.

CJC-1295 (without DAC) binds to growth hormone-releasing hormone (GHRH) receptors on somatotroph cells in the pituitary, activating cAMP/PKA intracellular signaling pathways that support growth hormone axis release mechanisms.

In experimental research, these peptides are studied together because they act on separate but complementary signaling networks — Ipamorelin on the ghrelin receptor and CJC-1295 (without DAC) on the GHRH receptor — allowing simultaneous investigation of multiple mechanisms involved in growth hormone axis regulation.

Compared with CJC-1295 with DAC, which binds to serum proteins and has an extended presence, CJC-1295 (without DAC) has a relatively short half-life, generally on the order of tens of minutes to about an hour in experimental systems, enabling more pulsatile signaling.

Studies indicate that Ipamorelin and CJC-1295 (without DAC) can modulate endogenous growth hormone axis activity through separate signaling pathways. CJC-1295 elicits more prolonged activation of growth hormone release mechanisms, while Ipamorelin produces rapid but short-lived signaling responses, allowing researchers to analyze patterns of hormone secretion and downstream intracellular effects.

Research Use Only – Legal Disclaimer

All Simple Peptide products labeled as Research Use Only (RUO) are intended strictly for laboratory, investigational, and scientific research purposes. These materials are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind.

By purchasing or using RUO materials, you acknowledge that they will be handled only within an appropriate research environment by qualified personnel who understand the risks, limitations, and regulatory requirements associated with experimental compounds. Products must not be administered to humans or animals, offered as therapeutic agents, or represented as safe or effective for any medical purpose.

Use of these materials is entirely at your own risk. Simple Peptide assumes no liability for misuse, unsafe handling, improper application, or any regulatory or compliance issues arising from their use.

Frequently bought together: Kisspeptin 10MG, KPV 10MG, L-Carnitine 5000MG